Risks of freezing injury in donor liver transplantation: The case of advanced organ preservation

Our educational webinar on September 14th examined the standard process of procuring a donor liver, with a concentrated focused on assessing the impact of cold preservation. How do colder temperatures…

Continue ReadingRisks of freezing injury in donor liver transplantation: The case of advanced organ preservation

Paragonix Technologies Celebrates Clinical Milestone of over 2,000 Organs Preserved and Transported for Transplantation

Now over 1 in 5 Thoracic Organ Transplants are preserved using Paragonix Advanced Organ Preservation and Tracking Technology CAMBRIDGE, MASSACHUSETTS – August 17, 2022 - Paragonix Technologies, Inc. is announcing a…

Continue ReadingParagonix Technologies Celebrates Clinical Milestone of over 2,000 Organs Preserved and Transported for Transplantation

Paragonix Expands Research for Advanced Organ Preservation Clinical Registries

Increased participation in the GUARDIAN-Liver Clinical registry follows in the footsteps of the GUARDIAN-Heart and GUARDIAN-Lung, expanding clinical research in Advanced Organ Preservation CAMBRIDGE, MASSACHUSETTS – July 19, 2022 - Paragonix…

Continue ReadingParagonix Expands Research for Advanced Organ Preservation Clinical Registries

Paragonix Technologies Announces Expanded Adoption of their LIVERguard™ System at the 2022 American Transplant Congress

With clinical utilization at 8 U.S. Liver Transplant Centers since commercial introduction in January 2022, Paragonix recently showcased its donor liver technology at the 2022 American Transplant CongressCAMBRIDGE, MASSACHUSETTS – Paragonix…

Continue ReadingParagonix Technologies Announces Expanded Adoption of their LIVERguard™ System at the 2022 American Transplant Congress

Paragonix Technologies SherpaPak® Improves 1-Year Survival in Heart Transplant Patients in Real-World Study

GUARDIAN Registry data presented at ISHLT 2022 has shown a 72% reduction (p=0.005) in Severe PGD (primary graft dysfunction) and a 39% reduction (p=0.03) in Mechanical Circulatory Support, in addition…

Continue ReadingParagonix Technologies SherpaPak® Improves 1-Year Survival in Heart Transplant Patients in Real-World Study

Paragonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”

Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research…

Continue ReadingParagonix Technologies Hosting ISHLT Industry Symposium “Improving Transplant Outcomes with Advanced Donor Heart Preservation & Transport”

Paragonix Technologies Presenting New Organ Preservation Research at the International Society of Heart and Lung Transplantation 2022 Annual Meeting

Paragonix medical devices featured in multiple seminars and posters at Boston’s ISHLT 2022 Annual Meeting outcomes CAMBRIDGE, MASSACHUSETTS – Paragonix Technologies, Inc., a leading organ preservation provider, is presenting new research…

Continue ReadingParagonix Technologies Presenting New Organ Preservation Research at the International Society of Heart and Lung Transplantation 2022 Annual Meeting

Paragonix SherpaPak featured in KMTV News segment “Glenwood man is first-ever SherpaPak heart transplant recipient”

https://youtu.be/Ja5MzXpjbLA From KMTV News Now Omaha OMAHA, Neb. (KMTV) — Looking at him, you might not know Tim Hagen is one in 7.9 billion. "When they found the cancer, the…

Continue ReadingParagonix SherpaPak featured in KMTV News segment “Glenwood man is first-ever SherpaPak heart transplant recipient”

University of Virginia Medical Center Completes First Successful Transplant Using the Paragonix SherpaPak® Cardiac Transport System

CAMBRIDGE, MASSACHUSETTS – February 8, 2022 – Paragonix Technologies announced the first successful heart transplant at the University of Virginia Medical Center using it’s SherpaPak Cardiac Transport System (CTS). The…

Continue ReadingUniversity of Virginia Medical Center Completes First Successful Transplant Using the Paragonix SherpaPak® Cardiac Transport System

Paragonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case

Device enables donor lungs to safely travel unprecedented distance of 4,788 Miles with a total ischemic time of over 13 hours CAMBRIDGE, MASSACHUSETTS – Feb. 2, 2021 – Paragonix Technologies announces…

Continue ReadingParagonix Technologies LUNGguard™ Used in Record Cross-Country Donor Lung Transplant Case